Last $130.22 USD
Change Today +2.40 / 1.88%
Volume 172.0K
UTHR On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 5:10 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Christopher Causey MBA

Director, Chairman of Compensation Committee and Member of Nominating & Governance Committee, United Therapeutics Corporation
AgeTotal Calculated CompensationThis person is connected to 12 board members in 1 different organizations across 1 different industries.

See Board Relationships
51$464,100

Background*

Mr. Christopher Causey, also known as Chris, MBA has been a Principal of Causey Consortium since 2002. Mr. Causey served as a Senior Marketing Officer in a variety of health care and technology companies. From 2001 to 2002, he served as Chief Marketing Officer at Definity Health Incorporated. From 1999 to 2001, Mr. Causey served as Vice President for Marketing at DirectAg.com Incorporated. From 1997 to 1999, Mr. Causey served as Vice President for Marketing at Allina ...

Read Full Background

Corporate Headquarters*

1040 Spring Street
Silver Spring, Maryland 20910

United States

Phone: 301-608-9292
Fax: 301-608-9291

Board Members Memberships*

Director
2003-Present
Director, Chairman of Compensation Committee and Member of Nominating & Governance Committee

Education*

MBA
George Washington University
BA
College of Wooster

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$82,500
Total Calculated Compensation$464,100
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
UTHR:US $130.22 USD +2.40

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
$1.0M
Jean-Paul Clozel M.D.Founder, Chief Executive Officer, Member of Management Board and Director
Actelion Ltd.
SFr.2.6M
Leonard Bell M.D.Co-Founder, Chairman of the Board and Chief Executive Officer
Alexion Pharmaceuticals, Inc.
$1.2M
Mark C. Rohr Chairman of the Board, Chief Executive Officer and President
Celanese Corporation
$1.0M
Shigenobu Maekawa President and Representative Director
Nippon Shinyaku Co. Ltd.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UNITED THERAPEUTICS CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.